Do you want to read an article? Please log in or register.
Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial
Tuberculosis
![](https://cdn.healthbook.network/wp-content/uploads/2018/03/like_hb.png)